These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6111394)

  • 1. Characterization and classification of rat leukemias and lymphomas by membrane markers.
    Moriuchi T; Kasai M; Yamaguchi H; Kobayashi H
    Cancer Res; 1981 May; 41(5):1938-42. PubMed ID: 6111394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterologous antiserum to chemically induced rat non-T, non-B leukemia and its application to characterization of rat leukemias.
    Moriuchi T; Kasai M; Yamaguchi H; Kobayashi H
    Cancer Res; 1981 Feb; 41(2):708-12. PubMed ID: 6969631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell markers in lymphomas and leukemias.
    Bowman WP; Melvin S; Mauer AM
    Adv Intern Med; 1980; 25():391-425. PubMed ID: 6987847
    [No Abstract]   [Full Text] [Related]  

  • 4. The nature of childhood leukemia and lymphoma.
    Kersey JH; Gajl-Peczalska KJ; Coccia PF; Nesbit ME
    Am J Pathol; 1978 Feb; 90(2):487-95. PubMed ID: 304675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymic origin of the prolactin-dependent Nb2 lymphoma cell line.
    Fleming WH; Pettigrew NM; Matusik RJ; Friesen HG
    Cancer Res; 1982 Aug; 42(8):3138-41. PubMed ID: 7046917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibody studies in B(non-T)-cell malignancies.
    Shimoyama M; Minato K; Tobinai K; Nagai M; Hirose M
    Jpn J Clin Oncol; 1983 Sep; 13(3):477-88. PubMed ID: 6417373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
    Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface markers in leukemias and lymphomas.
    Siegal FP; Filippa DA; Koziner B
    Am J Pathol; 1978 Feb; 90(2):451-60. PubMed ID: 304673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low incidence of gross leukemia virus-induced lymphomas in spontaneously hypertensive rats with thymic dysfunction.
    Takeichi N; Suzuki K; Kobayashi H
    Cancer Res; 1984 Aug; 44(8):3241-4. PubMed ID: 6744261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
    Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
    Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell surface antigens expressed by subsets of pre-B cells and B cells.
    McKearn JP; Baum C; Davie JM
    J Immunol; 1984 Jan; 132(1):332-9. PubMed ID: 6606670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis and classification of hematologic tumors using anti-lymphocyte monoclonal antibodies].
    Kikuchi K
    Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):551-8. PubMed ID: 6603817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrophoretic mobility profiles of mouse leukemias. II. Electrophoresis of thymic lymphoma, myeloid leukemia and reticulum sarcoma cells.
    Bubeníková D; Bubeník J
    Neoplasma; 1983; 30(6):691-700. PubMed ID: 6361586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of monoclonal antibodies, morphology, and cytochemistry to probe the cellular heterogeneity of acute leukemia and lymphoma.
    LeBien TW; McKenna RW; Abramson CS; Gajl-Peczalska KJ; Nesbit ME; Coccia PF; Bloomfield CD; Brunning RD; Kersey JH
    Cancer Res; 1981 Nov; 41(11 Pt 2):4776-80. PubMed ID: 6945905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface markers, antigens, and receptors on murine T and B cells: part 2.
    Ahmed A; Smith AH
    Crit Rev Immunol; 1983; 4(1):19-94. PubMed ID: 6131792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
    Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
    Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reactivity of Leu 1 and T101 monoclonal antibodies with B cell lymphomas (correlations with other immunological markers).
    Al Saati T; Laurent G; Caveriviere P; Rigal F; Delsol G
    Clin Exp Immunol; 1984 Dec; 58(3):631-8. PubMed ID: 6239721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface marker identification of small cleaved follicular center cell lymphomas with a highly favorable prognosis.
    Rudders RA; Ahl ET; Delellis RA; Bernstein S; Begg CB
    Cancer Res; 1982 Jan; 42(1):349-53. PubMed ID: 7053861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies.
    Sugimoto T; Tatsumi E; Kemshead JT; Helson L; Green AA; Minowada J
    J Natl Cancer Inst; 1984 Jul; 73(1):51-7. PubMed ID: 6610792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome and cell surface marker studies in 1-propyl-1-nitrosourea-induced thymic lymphomas of the rat.
    Oikawa T; Takeichi N; Yamashina K; Yoshida MC; Sasaki M
    Cancer Genet Cytogenet; 1982 Dec; 7(4):327-38. PubMed ID: 7165868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.